Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06366672

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Evaluating the Durability of the Human Immune Response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine

Status
Active Not Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study is designed to evaluate the magnitude and duration of the human adaptive immune response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine in the blood, lung mucosa, skin and bone marrow.

Detailed description

Orthopoxvirus vaccination leads to very high magnitude antigen-specific T cell responses and neutralizing antibody responses that can be detected in blood decades after vaccination. Despite a large number of previous studies of human immune responses to Modified Vaccinia Ankara (MVA) vaccination in blood, very few of these previous studies evaluate the human mucosal immune response to MVA in the lung and skin, or the immune response to MVA vaccination in the bone marrow. The development of methods to explore human immune responses in these key immunologic compartments now allows the evaluation of the induction of immune responses in these human tissues using the MVA vaccine system.

Conditions

Interventions

TypeNameDescription
BIOLOGICALJYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) suspension for subcutaneous injectionlive, nonreplicating vaccine delivered according to the FDA approved package insert
PROCEDUREPhlebotomyResearch blood draw
PROCEDUREResearch bronchoscopyOutpatient research bronchoscopy with bronchoalveolar lavage and endobronchial biopsy performed with conscious sedation.
PROCEDURESkin punch biopsySkin punch biopsy performed with topical anesthesia.
PROCEDUREBone marrow aspirationBone marrow aspiration performed with local anesthesia.

Timeline

Start date
2024-06-10
Primary completion
2026-09-01
Completion
2026-12-01
First posted
2024-04-16
Last updated
2025-10-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06366672. Inclusion in this directory is not an endorsement.

Evaluating the Human Immune Response to the JYNNEOS Vaccine (NCT06366672) · Clinical Trials Directory